Neubase Therapeutics Inc. buy elfe
Start price
31.01.15
/
50%
€2,596.8
Target price
01.06.15
€4,800.0
Performance (%)
-64.20%
End price
01.06.15
€929.60
Summary
This prediction ended on 01.06.15 with a price of €929.60. The BUY prediction by elfe for Neubase Therapeutics Inc. performed very badly with a performance of -64.20%. elfe has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neubase Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -5.585% | -6.284% | 8.869% | 8.070% |
iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% | 28.955% |
iShares Nikkei 225® | -8.933% | -10.904% | 2.614% | -1.478% |
iShares S&P 500 | -6.148% | -7.562% | 17.896% | 31.811% |
Comments by elfe for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
Neue Wege und klare Lösungen, Ohr Pharmaceutical auf dem weg neuartige Therapien zu finden.
Marktplazierung: 172,85 Millionen Euro
Anzahl der Aktien: 25,39 Millionen
Kaufsignal
(Vom Mitglied beendet)